Insomnia Device Maker Cerêve Raises $38M From KKR, Others
Cerêve Inc., which is readying the launch of its U.S. Food and Drug Administration-approved insomnia treatment device, said Thursday that it has raised $38 million in a Series B funding round...To view the full article, register now.
Already a subscriber? Click here to view full article